The synthesis and biological activity of pyranonaphthoquione derivatives from Streptomyces sp. and their related substances

Bulletin of the Chemical Society of Japan

Volumn 77, Issue 10, 2004, Pages 1925-1930

  Shimbashi, Akiko ^a   Tsuchiya, Ayako ^a   Imoto, Masaya ^a   Nishiyama, Shigeru ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; DERIVATIVES; ENZYME INHIBITION; ENZYMES; SYNTHESIS (CHEMICAL);

BIOLOGICAL ACTIVITY; INHIBITORY ACTIVITIES; MICHAEL ADDITION; SYNTHETIC PATHWAY;

KETONES;

2 (1 BUTYL 3,4 DIHYDRO 10 HYDROXY 7 METHYLAMINO 6,9 DIOXOBENZO[G] 1H ISOCHROMEN 3 YL]ACETIC ACID; 7 (4 HYDROXYBUT 2 ENYL) 5 HYDROXY 6 (1 HYDROXYPENTYL) 2 METHYLAMINO 1,4 NAPHTHOQUINONE; CDC25A PHOSPHATASE; METHYL 2 (1 BUTYL 3,4 DIHYDRO 10 HYDROXY 7 METHOXY 6,9 DIOXOBENZO[G] 1H ISOCHROMEN 3 YL)ACETATE; METHYL 2 (1 BUTYL 3,4 DIHYDRO 10 HYDROXY 7 METHYLAMINO 6,9 DIOXOBENZO[G] 1H ISOCHROMEN 3 YL)ACETATE; PHOSPHATASE; PYRANONAPHTHOQUINONE DERIVATIVE; QUINONE DERIVATIVE; UNCLASSIFIED DRUG; VANADATE SODIUM;

ARTICLE; BROMINATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ISOMERIZATION; MICHAEL ADDITION; STREPTOMYCES;

EID: 8444233646     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.77.1925     Document Type: Article

References (32)

1. P. Kulanthaivel, T. J. Perun, Jr., M. D. Belvo, R. J. Strobel, D. C. Paul, and D. C. Williams, J. Antibiot., 52, 256 (1999).
2. a) S. Jinno, K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama, EMBO J., 13, 1549 (1994).
3. b) I. Hoffmann, G. Draetta, and E. Karsenti, EMBO J., 13, 4302 (1994).
4. a) K. Galaktionov, A. K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach, Science, 269, 1575 (1995).
5. b) K. Galaktionov, X. Chen, and D. Beach, Nature, 382, 511 (1996).
6. c) D. Gasparotto, R. Maestro, S. Piccinin, T. Vukosavljievic, L. Barzan, S. Sulfaro, and M. Boiocchi, Cancer Res., 57, 2366 (1997).
7. d) W. G. Wu, Y. H. Fan, B. L. Kemp, G. Walsh, and L. Mao, Cancer Res., 58, 4082 (1998).
8. e) D. Dixon, T. Moyana, and M. J. King, Exp. Cell Res., 240, 236 (1998).
9. f) M. G. Cangi, B. Cukor, P. Soung, S. Signoretti, G. Moreira, M. Ranashinge, B. Cady, M. Pagano, and M. Loda, J. Clin. Invest., 106, 753 (2000).
10. a) S. Omura, H. Tanaka, Y. Koyama, R. Oiwa, M. Katagiri, J. Awaya, T. Nagai, and T. Hata, J. Antibiot., 27, 363 (1974).
11. b) H. Tanaka, Y. Koyama, J. Awaya, H. Marumo, R. Oiwa, M. Katagiri, T. Nagai, and S. Omura, J. Antibiot., 28, 860 (1975).
12. c) H. Tanaka, Y. Koyama, T. Nagai, H. Marumo, and S. Omura, J. Antibiot., 28, 868 (1975).
13. H. Schmid and A. Ebnöther, Helv. Chim. Acta, 34, 1041 (1951).
14. a) J. C. Van Meter, M. Dann, and N. Bohonos, "Antibacterial Agents Annual-1960," Plenum Press, New York, N. Y. (1961), p. 77.
15. b) G. A. Ellestad, M. P. Kunstmann, H. A. Whaley, and E. L. Patterson, J. Am. Chem. Soc., 90, 1325 (1968).
16. Preliminary report see: a) A. Shimbashi, Y. Ishikawa, and S. Nishiyama, Tetrahedron Lett., 45, 939 (2004). b) M. Iinuma, T. Tanaka, and S. Matsuura, Chem. Pharm. Bull. 32, 2296 (1984).
17. Preliminary report see: a) A. Shimbashi, Y. Ishikawa, and S. Nishiyama, Tetrahedron Lett., 45, 939 (2004). b) M. Iinuma, T. Tanaka, and S. Matsuura, Chem. Pharm. Bull. 32, 2296 (1984).
18. 4.
19. W. P. Reeves and R. M. King, Synth. Commun., 23, 855 (1993).
20. a) E. J. Corey and M. Chaykovsky, J. Am. Chem. Soc., 87, 1353 (1965).
21. b) S. Kulasegaram and R. J. Kulawiec, J. Org. Chem., 62, 6547 (1997).
22. R. L. Settine, G. L. Parks, and G. L. K. Hunter, J. Org. Chem., 29, 616 (1964).
23. 3 conditions, two alkyl substituents of the dihydropyran moiety adopt thermodynamically the more favorable trans-form than the corresponding cis-form. Examples of stability of the trans-form by thermodynamic control: a) M. F. Semmehak and A. Zask, J. Am. Chem. Soc., 105, 2034 (1983). b) A. D. Webb and T. M. Harris, Tetrahedron Lett., 18, 2069 (1977). c) T.-T. Li and R. H. Ellison, J. Am. Chem. Soc., 100, 6263 (1978). d) T. Masquelin, U. Hengartner, and J. Streith, Synthesis, 1995, 780.
24. 3 conditions, two alkyl substituents of the dihydropyran moiety adopt thermodynamically the more favorable trans-form than the corresponding cis-form. Examples of stability of the trans-form by thermodynamic control: a) M. F. Semmehak and A. Zask, J. Am. Chem. Soc., 105, 2034 (1983). b) A. D. Webb and T. M. Harris, Tetrahedron Lett., 18, 2069 (1977). c) T.-T. Li and R. H. Ellison, J. Am. Chem. Soc., 100, 6263 (1978). d) T. Masquelin, U. Hengartner, and J. Streith, Synthesis, 1995, 780.
25. 3 conditions, two alkyl substituents of the dihydropyran moiety adopt thermodynamically the more favorable trans-form than the corresponding cis-form. Examples of stability of the trans-form by thermodynamic control: a) M. F. Semmehak and A. Zask, J. Am. Chem. Soc., 105, 2034 (1983). b) A. D. Webb and T. M. Harris, Tetrahedron Lett., 18, 2069 (1977). c) T.-T. Li and R. H. Ellison, J. Am. Chem. Soc., 100, 6263 (1978). d) T. Masquelin, U. Hengartner, and J. Streith, Synthesis, 1995, 780.
26. 3 conditions, two alkyl substituents of the dihydropyran moiety adopt thermodynamically the more favorable trans-form than the corresponding cis-form. Examples of stability of the trans-form by thermodynamic control: a) M. F. Semmehak and A. Zask, J. Am. Chem. Soc., 105, 2034 (1983). b) A. D. Webb and T. M. Harris, Tetrahedron Lett., 18, 2069 (1977). c) T.-T. Li and R. H. Ellison, J. Am. Chem. Soc., 100, 6263 (1978). d) T. Masquelin, U. Hengartner, and J. Streith, Synthesis, 1995, 780.
27. a) X. L. Tao, J.-F. Cheng, S. Nishiyama, and S. Yamamura, Tetrahedron, 50, 2017 (1994).
28. b) The cis- and trans-isomers were formed in a ratio of ca. 1:3. The diastereomeric mixture was inseparable.
29. Because the diastereomeric mixture was inseparable, crude 14 was used for Cdc25A phosphatase inhibition assay.
30. 2, changed to ca. 4:1 by KOH, which might induce isomerization through successive β-elimination and Michael addition reactions.
31. 4OAc-MeCN - 3/2).
32. H. He, H. Y. Yang, S. W. Luckman, D. M. Roll, and G. T. Carter, J. Antibiot., 55, 1072 (2002).